NCCNCLINICALPRACTICEGUIDELINESINONCOLOGYBreastCancer,Version3.2020WilliamJ.Gradishar,MD1,*;BenjaminO.Anderson,MD2,*;JameAbraham,MD3;RebeccaAft,MD,PhD4;DoreenAgnese,MD5;KimberlyH.Allison,MD6;SarahL.Blair,MD7;HaroldJ.Burstein,MD,PhD8;ChauDang,MD9;AnthonyD.Elias,MD10;SharonH.Giordano,MD,MPH11;...
Several letters to the editor and a response are presented regarding the article "The Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in average-risk women aged 40-74 years," by M. Tonelli, S. C. Gorber, and M. Joffres in the 2011 issue....
1,2 In recent years, the treatment landscape of ABC has evolved dramatically with the development of novel anti-cancer agents, such as CDK (cyclin-dependent kinase) 4/6 inhibitors and ADCs (antibody-drug conjugates). Based on the Guidelines for Clinical Diagnosis and Treatment of Advanced ...
On February 2nd,World Cancer Day 2013 in China hosted by China Anti-Cancer Association(CACA),and jointly undertaken by Cancer Rehabilitation and Palliative... 广东省抗癌协会肝癌专业委员会,中山大学肿瘤防治中心肝胆科 - 《中国实用外科杂志》 被引量: 0发表: 2014年 加载更多0关于...
NCCN Guidelines ® Insights Breast Cancer, Version 3.2013 Featured Updates to the NCCN Guidelines Richard L. Theriault, DO 1 ; Robert W. Carlson, MD 2 ; Craig Allred, MD 3 ; Benjamin O. Anderson, MD 4 ; Harold J. Burstein, MD, PhD 5 ; Stephen B. Edge, MD 6 ; William B. ...
PDFFull Text(624)Reporting ChecklistData Sharing StatementPeer Review FileCOI FormOpen Access Clinical Practice Guideline Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024 Jianbin Li,Chunfang Hao,Kun Wang,Jian Zhang,Jiayi Chen,Yueping Liu,Jianyun Nie,Min Yan,Qiang Liu,Cuizhi...
This guideline updates the American Cancer Society breast cancer screening recommendations for women at average risk for breast cancer.
Conclusion The evidence-base on which these guidelines have been developed is lacking. It is apparent that well designed randomised controlled trials are needed urgently if we are to understand the most appropriate and effective ways of following up patients with breast cancer. 展开 ...
William J. Gradishar, MD, highlights the inclusion of abemaciclib in the NCCN Guidelines for select high-risk early-stage breast cancer patients, anticipates the potential for ribociclib to secure a similar guideline position, and emphasizes the importan
The guideline on COVID-19–related triage of patients with breast cancer was released on March 24, 2020 by the COVID 19 Pandemic Breast Cancer Consortium, which comprises representatives from the National Accreditation Program for Breast Centers (NAPBC), the Commission on Cancer (CoC), the Amer...